为解决慢性肾病（CKD）缺乏有效治疗手段、急性肾损伤（AKI）无治愈方法且细胞疗法需大量细胞等问题，研究人员开展关于人诱导多能干细胞衍生的肾祖细胞（hiPSC-NPCs）治疗 AKI 和 CKD 的研究。结果显示其可缓解肾损伤，或为治疗肾病开辟新途径。 全球范围内 ...

急性肾损伤肾功能恢复的研究进展 急性肾损伤（AKI）是全球范围内肾脏病学面临的重大挑战之一，与慢性肾脏病（CKD）共同构成肾脏疾病领域的两大难题。AKI 并非单一疾病，而是由多种肾性和肾外疾病引发的临床状况，最终会导致肾脏排泄功能受损。其在医院 ...

The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...

AKI and CKD affect millions worldwide, with AKI accounting for a significant proportion of hospital and intensive care unit admissions. The sudden decline in kidney function leads to severe ...

AKI and CKD affect millions worldwide, with AKI accounting for a significant proportion of hospital and intensive care unit admissions. The sudden decline in kidney function leads to severe ...

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.